|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| Sep. 17 | Pfizer, BioNTech Secure Health Canada Authorization for Omicron XFG-Adapted COVID-19 Vaccine | MT |
| Sep. 17 | Bavarian Nordic Names Tarja Stenvall as New CEO | FW |
| Market Cap | 158B 137B 130B 118B 220B 15,088B 222B 1,547B 598B 7,668B 592B 579B 24,546B | P/E 2026 * |
17.4x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 205B 179B 169B 154B 287B 19,635B 288B 2,013B 778B 9,979B 770B 753B 31,945B | EV / Sales 2026 * |
3.29x | EV / Sales 2027 * | 3.32x |
| Free-Float |
59.05% | Yield 2026 * |
6.23% | Yield 2027 * | 6.28% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.28% | +2.62% | +51.61% | +100.19% | 1,014B | |
| +1.10% | +1.45% | +52.49% | +67.37% | 644B | |
| +0.58% | +3.54% | +19.57% | +73.56% | 464B | |
| -0.36% | +4.54% | +38.71% | +38.21% | 354B | |
| +1.52% | +3.46% | +20.13% | +25.75% | 265B | |
| +2.41% | +5.70% | +9.06% | +13.60% | 253B | |
| +0.91% | -0.70% | +38.25% | +45.67% | 203B | |
| +2.48% | -2.43% | -24.40% | -58.09% | 186B | |
| +2.17% | +4.20% | +34.41% | +99.41% | 183B | |
| Average | +0.92% | +1.98% | +26.65% | +45.07% | 396.31B | |
| Weighted average by Cap. | +0.20% | +2.35% | +35.35% | +61.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 54.21B 51.3B 46.61B 87.08B 5,960B 87.51B 611B 236B 3,029B 234B 229B 9,697B | 59.77B 52.06B 49.27B 44.76B 83.63B 5,724B 84.04B 587B 227B 2,909B 225B 220B 9,312B |
| Net income | 8.9B 7.75B 7.34B 6.67B 12.45B 852B 12.51B 87.39B 33.79B 433B 33.44B 32.69B 1,387B | 11.08B 9.65B 9.13B 8.3B 15.5B 1,061B 15.58B 109B 42.07B 539B 41.62B 40.7B 1,726B |
| Net Debt | 47.48B 41.36B 39.14B 35.56B 66.44B 4,548B 66.77B 466B 180B 2,311B 178B 174B 7,398B | 40.98B 35.69B 33.78B 30.69B 57.34B 3,925B 57.62B 402B 156B 1,995B 154B 151B 6,385B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
